Results 81 to 90 of about 14,035,857 (361)

Predictors of hospital mortality in the global registry of acute coronary events.

open access: yesArchives of Internal Medicine, 2003
BACKGROUND Management of acute coronary syndromes (ACS) should be guided by an estimate of patient risk. OBJECTIVE To develop a simple model to assess the risk for in-hospital mortality for the entire spectrum of ACS treated in general clinical ...
C. Granger   +10 more
semanticscholar   +1 more source

Recognition and Ranking Critical Success Factors of Business Intelligence in Hospitals -- Case Study: Hasheminejad Hospital [PDF]

open access: yes, 2014
Business Intelligence, not as a tool of a product but as a new approach is propounded in organizations to make tough decisions in business as shortly as possible. Hospital managers often need business intelligence in their fiscal, operational, and clinical reports and indices. The main goal of recognition and ranking CSF is implementation of a business
arxiv   +1 more source

The PTTG1/VASP axis promotes oral squamous cell carcinoma metastasis by modulating focal adhesion and actin filaments

open access: yesMolecular Oncology, EarlyView.
VASP was found to be overexpressed in metastatic oral squamous cell carcinoma (OSCC) tissues. Notably, PTTG1‐ and VASP‐deficient OSCC cells demonstrated suppressed metastatic properties by disrupting the interaction between the cytoskeleton and focal adhesion (FAs) in the filopodia region.
Suyeon Park   +6 more
wiley   +1 more source

Use of cangrelor in percutaneous coronary interventions: a “new” weapon in the antithrombotic therapeutic armamentarium

open access: yesREC: Interventional Cardiology (English Ed.), 2020
During the second half of 2019, cangrelor started selling in our country, a “new” antiplatelet drug with especial pharmacological properties that make it especially appealing for the management of certain clinical situations in the percutaneous coronary ...
José Luis Ferreiro   +1 more
doaj   +1 more source

First hospital outbreak of the globally emerging Candida auris in a European hospital

open access: yesAntimicrobial Resistance and Infection Control, 2016
Candida auris is a globally emerging multidrug resistant fungal pathogen causing nosocomial transmission. We report an ongoing outbreak of C. auris in a London cardio-thoracic center between April 2015 and July 2016. This is the first report of C.
S. Schelenz   +11 more
semanticscholar   +1 more source

Obesity alters the fitness of peritumoral adipose tissue, exacerbating tumor invasiveness in renal cancer through the induction of ADAM12 and CYP1B1

open access: yesMolecular Oncology, EarlyView.
Tumor microenvironment drives cancer formation and progression. We analyzed the role of human cancer‐associated adipocytes from patients with renal cell carcinoma (RCC) stratified as lean, overweight, or obese. RNA‐seq demonstrated that, among the most altered genes involved in the tumor–stroma crosstalk, are ADAM12 and CYP1B1, which were proven to be ...
Sepehr Torabinejad   +13 more
wiley   +1 more source

Conferencias anatomoclinicas

open access: yesRevista de la Facultad de Medicina, 1954
Caso número once: EI enfermo ingresa al Servicio de Clínica Semiológica del Profesor Forero Villaveces el 20 de agosto de 1951, por presentar anorexia, dolor epigástrico, vómito postprandial, flatulencia, enflaquecimiento progresivo y gran astenia / Caso
San Juan de Dios Hospital
doaj   +2 more sources

The Vanishing Discount Method for Stochastic Control: A Linear Programming Approach [PDF]

open access: yes, 2023
Under consideration are convergence results between optimality criteria for two infinite-horizon stochastic control problems: the long-term average problem and the $\alpha$-discounted problem, where $\alpha \in (0,1]$ is a given discount rate.
Hospital, Brian
core   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

open access: yesMolecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou   +11 more
wiley   +1 more source

Conferencias anatomoclínicas: caso no. diez y nueve

open access: yesRevista de la Facultad de Medicina, 1955
z. J. M. 60 años. Ciudad de origen: Simijaca. Ciudad de procedencia: Tena. Servicio del Prof. Carlos Trujillo Gutiérrez. NOTA CLINICA: El enfermo ingresa al Servicio de Clínica quirúrgica del Prof.
San Juan de Dios Hospital
doaj  

Home - About - Disclaimer - Privacy